High expression of genes related to the immune response was more frequent in melanomas of patients who achieved complete remission with BRAF and MEK inhibitors, while high expression of keratin and kallikrein genes was more frequent in melanomas of patients with rapid progression [13]. The gene discussed is MAP2K7; the disease is melanoma.